E-Cigarettes and Cardiovascular Disease

Featured Topic — Wednesday, April 28, 2021 — 4:00 PM - 5:30 PM — Virtual Session, Room APS-7
Cardiovascular Section — Chair: Loren E. Wold — Co-Chair: Shampa Chatterjee

The recent popularity of electronic cigarettes (ECs) has caused quick and widespread action by regulatory groups and the scientific community. What began as an alternative to cigarette smoking developed into an independent phenomenon with an extensive usage-base: former smokers and new users, and adults and youth alike. EC usage and its effects on health are complicated to study due to its ever-evolving nature and presence of an endless variety of devices, “e-liquid,” and flavorings. Despite this, this featured topic will focus on how EC use affects the heart as well as the lungs.

Speakers

• Introductions
  Dr. Wold and Dr. Chatterjee — Session Chairs
  4:00 PM - 4:02 PM


• Updates on the Cardiac Effects of E-Cigarette Aerosol Inhalation
  Laura Crotty-Alexander — Medicine, University of California-San Diego
  4:02 PM - 4:25 PM


• Moderated Discussion
  Loren Wold — Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University
  4:25 PM - 4:30 PM


• Abstract 1 - Chronic Inhaled Nicotine-Induced Pulmonary Hypertension and Right Ventricular Remodeling are Mediated by Angiotensin-II Type 1 Receptor
  Nicholas D. Fried — Physiology, Louisiana State University Health Sciences Center New Orleans
  4:30 PM - 4:45 PM


• Abstract 2 - Severity of Cerebrovascular Dysfunction Associated with Electronic Cigarette Wattage
  Emily N. Burrage — Neuroscience, West Virginia University
  4:45 PM - 5:00 PM


• Abstract 3 - The Effects of Pod-Based e-liquids on Vascular Endothelial Cell Function
  Sana Majid — Boston University School of Medicine
  5:00 PM - 5:15 PM


• Abstract 4 - Impact of JUULing (JUUL e-cigarette) on Central Hemodynamics and Arterial Stiffness
  Klaas Frederik Franzen — Medical Clinic III, University Medical Center Schleswig Holstein
  5:15 PM - 5:30 PM